Dissolved Oxygen in Blood: Henry's Law, the 0.003 × PO₂ Constant, and Clinical Significance

Henry's law states that the amount of gas dissolved in a liquid at a given temperature is directly proportional to the partial pressure of that gas in equilibrium with the liquid. For oxygen in human plasma at body temperature (37°C), this relationship is expressed as dissolved O₂ = α × PO₂, where α is the Bunsen solubility coefficient for oxygen in plasma, equal to 0.003 mL O₂ per deciliter per mmHg (0.003 mL O₂/dL/mmHg). This coefficient reflects the physicochemical properties of oxygen and plasma and is considered constant under physiological conditions of temperature, pH, and ionic strength.

The linear relationship between dissolved oxygen and partial pressure means that doubling PO₂ exactly doubles the dissolved oxygen content. At a normal arterial PaO₂ of 100 mmHg, dissolved oxygen is 0.003 × 100 = 0.30 mL O₂/dL. Compared to the hemoglobin-bound component of approximately 19–20 mL O₂/dL, dissolved oxygen represents only about 1.5% of total arterial oxygen content. This explains why physiologists and clinicians historically gave the dissolved fraction relatively little attention under normal conditions — hemoglobin overwhelmingly dominates oxygen transport in the blood.

The solubility coefficient is temperature-dependent: as temperature decreases, gas solubility in liquids increases according to thermodynamic principles. During therapeutic hypothermia (core temperature approximately 33°C), the oxygen solubility coefficient rises slightly, resulting in marginally higher dissolved oxygen at any given PO₂. Conversely, fever increases body temperature and reduces oxygen solubility, though these changes are quantitatively small (approximately 2% per degree Celsius) and rarely alter clinical decision-making. The 0.003 value used in standard oxygen content equations assumes a body temperature of 37°C, and temperature correction is applied in blood gas analyzers when sample temperature differs from the measurement temperature.

In the arterial oxygen content formula CaO₂ = (1.34 × Hb × SaO₂) + (0.003 × PaO₂), the second term represents dissolved oxygen and is calculated simply by multiplying the oxygen solubility coefficient (0.003 mL O₂/dL/mmHg) by the arterial partial pressure of oxygen in mmHg. For a patient breathing room air with PaO₂ = 95 mmHg, dissolved oxygen = 0.003 × 95 = 0.285 mL O₂/dL. When breathing 100% oxygen via a non-rebreather mask achieving PaO₂ = 500 mmHg, dissolved oxygen rises to 0.003 × 500 = 1.5 mL O₂/dL — still modest compared to hemoglobin-bound oxygen but five times the room air value.

The venous blood dissolved oxygen term follows the same calculation using the mixed venous partial pressure: dissolved venous O₂ = 0.003 × PvO₂. At a normal PvO₂ of 40 mmHg, this equals 0.12 mL O₂/dL. The dissolved oxygen component of the arteriovenous oxygen difference is therefore 0.285 − 0.12 = 0.165 mL O₂/dL under room air conditions, representing only about 3–4% of the total arteriovenous difference. For this reason, some simplified Fick equation implementations omit the dissolved oxygen term entirely, calculating oxygen content from the hemoglobin-bound component alone, accepting the minor systematic error in exchange for computational simplicity.

Whether to include the dissolved oxygen term depends on clinical context and desired precision. In routine Fick cardiac output calculations at the catheterization laboratory where PaO₂ is near normal, omitting the dissolved fraction introduces less than 2% error in the final cardiac output value — generally within the measurement uncertainty of VO₂ and saturation determinations. However, when patients are receiving high FiO₂ resulting in PaO₂ values above 300 mmHg, or when hyperbaric conditions are present, the dissolved fraction becomes large enough that its omission would introduce clinically meaningful error. Best practice is to always include the term for maximal accuracy.

Hyperbaric oxygen (HBO) therapy dramatically increases dissolved oxygen by raising the partial pressure of inspired oxygen to supraphysiological levels. At 3 atmospheres absolute (ATA) breathing 100% oxygen, PaO₂ can exceed 2000 mmHg, yielding dissolved oxygen of 0.003 × 2000 = 6.0 mL O₂/dL. This value approaches the typical resting oxygen consumption per circulatory pass (approximately 5 mL O₂/dL arteriovenous difference), meaning that dissolved oxygen alone can theoretically sustain basal metabolic requirements without any hemoglobin contribution. This principle underlies the use of HBO therapy in severe carbon monoxide poisoning and life-threatening anemia where hemoglobin oxygen-carrying capacity is critically impaired.

In severe anemia where hemoglobin levels are critically low and transfusion is unavailable or refused (as in some Jehovah's Witness patients), maximizing dissolved oxygen through high FiO₂ supplementation and potentially hyperbaric oxygen becomes a temporizing life-saving strategy. A patient with Hb of 3 g/dL has a hemoglobin-bound CaO₂ of only approximately 4 mL O₂/dL even with full saturation. In this extreme scenario, achieving a PaO₂ of 500 mmHg on high-flow oxygen adds 1.5 mL O₂/dL from dissolved oxygen — a 37% increase in total CaO₂ — which may provide the marginal oxygen delivery needed to prevent fatal tissue hypoxia while definitive management is arranged.

Extreme hyperoxia — deliberately achieved in certain research protocols and select critical care scenarios — also elevates dissolved oxygen substantially. Patients on extracorporeal membrane oxygenation (ECMO) can achieve PaO₂ values of 300–500 mmHg, and the dissolved oxygen contribution should be included in oxygen content and delivery calculations for accurate hemodynamic profiling. Additionally, during cardiopulmonary bypass with hyperoxic perfusion, the dissolved fraction can contribute meaningfully to total oxygen delivery, particularly during hypothermic conditions when metabolic demand is reduced and the additional dissolved oxygen may exceed tissue requirements even with reduced hemoglobin concentrations from hemodilution.

Modern blood gas analyzers measure PaO₂ directly using a Clark-type polarographic oxygen electrode, which generates a current proportional to the partial pressure of dissolved oxygen in the blood sample. The PaO₂ value reported on a blood gas result reflects only the dissolved fraction — it does not indicate how much oxygen is bound to hemoglobin. A normal PaO₂ of 80–100 mmHg on room air indicates adequate alveolar gas exchange, but without concurrent hemoglobin and saturation data, PaO₂ alone cannot define total oxygen content. This is why comprehensive hemodynamic assessment requires a full blood gas panel including co-oximetry and hemoglobin measurement.

The alveolar-arterial oxygen gradient (A-a gradient) is calculated using PaO₂ and provides a measure of gas exchange efficiency that is directly relevant to dissolved oxygen. A widened A-a gradient indicates impaired oxygen transfer across the alveolar-capillary membrane, as seen in pulmonary embolism, pneumonia, or interstitial lung disease, which reduces PaO₂ and therefore reduces the dissolved oxygen contribution to CaO₂. The A-a gradient is calculated as: A-a gradient = [FiO₂ × (Patm − PH₂O) − (PaCO₂ ÷ RQ)] − PaO₂, where Patm is atmospheric pressure, PH₂O is water vapor pressure (47 mmHg at 37°C), and RQ is the respiratory quotient (typically 0.8). A normal A-a gradient for a young adult breathing room air is approximately 5–15 mmHg and increases with age.